Prime Medicine slips after Q4 updates
Source: SeekingAlpha
2026-03-03 13:22:14 ET
More on Prime Medicine
- Prime Medicine, Inc. (PRME) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Prime: Maintaining 'Buy' On Solidified Catalysts For Wilson's Disease And Beyond
- Seeking Alpha’s Quant Rating on Prime Medicine
- Historical earnings data for Prime Medicine
- Financial information for Prime Medicine
Read the full article on Seeking Alpha
For further details see:
Prime Medicine slips after Q4 updates
First Trust Heitman Global Prime Real Estate ETF
NASDAQ: PRME
PRME Trading
6.19% G/L:
$4.115 Last:
1,469,571 Volume:
$3.88 Open:
PRME Latest News
March 03, 2026 08:00:00 am
Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates
PRME Stock Data
$629,079,643
97,403,551
13.07%
59
N/A
Biotechnology & Life Sciences
Healthcare
US
Cambridge
